Nvidia Invests $5B in Intel | Bloomberg Businessweek Daily 9/18/2025

The Bloomberg Businessweek Daily episode from September 18, 2025, covers Nvidia’s historic $5 billion investment in Intel to jointly develop advanced chips, highlighting its impact on the semiconductor industry, national security, and U.S. efforts to reduce reliance on Taiwan-based manufacturers amid geopolitical tensions. The episode also discusses President Trump’s legal battle over Federal Reserve governance and advancements in women’s health research, emphasizing the importance of innovation, access to care, and consistent public health messaging.

The Bloomberg Businessweek Daily episode from September 18, 2025, opens with a focus on the surprising $5 billion investment by Nvidia into Intel, a move described as historic by Nvidia’s CEO Jensen Huang. This collaboration aims to develop chips for personal computers and data centers, combining Intel’s expertise in central processing units (CPUs) with Nvidia’s leadership in graphics processing units (GPUs). The investment has led to a significant surge in Intel’s stock price, marking its best one-day gain since 1987. The deal reportedly predates recent political developments, with Nvidia and Intel emphasizing that the U.S. administration was not involved in initiating the partnership, although the Trump administration had encouraged Nvidia to invest in Intel about nine months prior.

The discussion then shifts to the broader semiconductor industry and national security implications. Experts highlight the strategic importance of Intel’s manufacturing capabilities in the U.S., especially as the country seeks to reduce reliance on Taiwan Semiconductor Manufacturing Company (TSMC) amid geopolitical tensions involving China and Taiwan. While Intel is not currently at the cutting edge of chip manufacturing compared to TSMC, the investment from Nvidia and SoftBank is seen as a step toward strengthening Intel’s position. Analysts note that Intel needs to secure large-scale customers to scale its manufacturing and compete effectively, with Nvidia potentially playing a key role in this effort.

The episode also covers the ongoing “chip war,” emphasizing the geopolitical stakes tied to semiconductor production. The U.S. government views Intel’s success as crucial for national security, aiming to diversify chip manufacturing away from Taiwan due to the risk of conflict in the region. Experts caution that while TSMC is expanding its U.S. presence, particularly in Arizona, its core research and development remain in Taiwan, keeping the island central to the global tech supply chain. The potential for conflict in the Taiwan Strait is acknowledged as a significant risk, prompting countries and companies to prepare for supply chain disruptions.

In addition to tech and finance, the program addresses a high-profile legal battle involving President Trump’s attempt to fire Federal Reserve Governor Lisa Cook. The case raises questions about the independence of the Federal Reserve and the president’s authority to remove officials “for cause.” Legal experts explain that the Supreme Court’s decision could have far-reaching implications for the Fed’s governance and U.S. monetary policy. Market analysts note that while the immediate impact on bond markets has been limited, a ruling favoring the president could lead to increased volatility and concerns about the Fed’s independence.

Finally, the episode highlights developments in women’s health, featuring Dr. Blumenthal, the first Deputy Assistant Secretary for Women’s Health. She discusses the historical underfunding and lack of innovation in women’s health research and the recent surge in investments aimed at addressing critical issues such as maternal mortality, autoimmune diseases, and cardiovascular health. The conversation underscores the importance of education, access to care, and new technologies like telehealth and portable ultrasounds in improving outcomes. The segment also touches on public health concerns related to vaccine hesitancy and the potential consequences of changing vaccination guidelines, emphasizing the need for consistent public health messaging to prevent outbreaks of preventable diseases.